Basibas, Zyrelle Kate P.

HRN: 26-68-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/11/2025
02/17/2025
IVT
40mg
Q6
Cellulitis, Left Forearm
Waiting Final Action 
02/11/2025
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
02/11/2025
02/15/2025
ORAL
200/5ml 2ml
Od
Pcap B
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: